The purpose of this research is to compare the effectiveness of Tacrolimus and Rapamycin to
Tacrolimus and Methotrexate in the prevention of severe graft-versus-host-disease.
Graft-versus-host-disease (GVHD) is a risk associated with allogeneic hematopoietic cell
transplants (HCT). An allogeneic hematopoietic cell transplant is a transplant using bone
marrow and blood cells that come from someone other than the patient (a donor).
Phase:
Phase 2
Details
Lead Sponsor:
H. Lee Moffitt Cancer Center and Research Institute